coxiella burnetti
TRANSCRIPT
Milad shahini 4
HISTORY
First reported :The first reported was in Brisbane, Queensland, Australia, in 1935 by Derrick.
Isolated the organism :Burnet and his associate Freeman successfully isolated the organism and concurrently, a similar agent was isolated from ticks in Montana by Davis and Cox.
Named Coxiella burnetii :. In 1938 the organism was named Coxiella burnetii in honor of Cox and Burnet.
Milad shahini 5
CHARACTERISTICS
Obligate intracellular pathogen Proteobacteria Gram-negative Two antigenic phases
Phase 1: virulent Phase 2: less pathogenic
Stable and resistant
Milad shahini 7
MECHANISMSThe type IVB secretion systems of Coxiella burnetii and Legionella pneumophila.
Milad shahini 8
MECHANISMSRoles of type IV secretion system effectors during Coxiella burnetiiintracellular infection.
Cig57
Cig2
Milad shahini 9
DISEASEThe important disease in human is Q fever : Incubation: 2 to 5 weeks One organism may cause disease Humans are dead-end hosts Disease
Asymptomatic (50%) Acute Chronic
Milad shahini 10
TRANSMISSIONAerosol
Parturient fluids 109 bacteria released per gram of placenta
Urine, feces, milkDirect contactFomites IngestionArthropods (ticks)
Milad shahini 11
TRANSMISSION Person-to-person (rare)
Transplacental (congenital) Blood transfusions Bone marrow transplants Intradermal inoculation Possibly sexually transmitted
Milad shahini 12
DIAGNOSIS Serology (rise in titer)
IFA, CF, ELISA, micro-agglutination DNA detection methods
PCR Isolation of organism
Risk to laboratory personnel Rarely done
Milad shahini 13
TREATMENT Treatment
Doxycycline Chronic disease – long course
2 to 3 years of medication Immunity
Long lasting (possibly lifelong)
Milad shahini 14
A BIOLOGICAL WEAPON Accessibility Low infectious dose Stable in the environment Aerosol transmission WHO estimate
5 kg agent released on 5 million persons 125,000 ill - 150 deaths Could travel downwind for over 20 km